Two more local COVID-19 medicines put on China's insurance drug list - CGTN
China approves first domestic anti-COVID pill, Azvudine, as it battles new Omicron outbreaks | Fortune
China Approves First Domestic Oral Drug for COVID-19 | ChemLinked
Oral pill for COVID-19 approved by regulator - Chinadaily.com.cn
Frontiers | FNC: An Advanced Anticancer Therapeutic or Just an Underdog?
Azvudine - Wikipedia
Coronavirus: China allows use of HIV drug Azvudine for adult Covid-19 patients | South China Morning Post
China homegrown COVID pill included in national subsidy program - Nikkei Asia
Paxlovid: Beijing to distribute Pfizer antiviral drug as Covid wave strains health system | CNN
Azvudine Tablet: China approves Genuine Biotech's HIV drug for COVID patients, ET HealthWorld
China's First Homegrown COVID-19 Pill, Azvudine, is Priced at 270 Yuan Per Bottle | ChemLinked
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients | Signal Transduction and Targeted Therapy
China Clears HIV Oral Antiviral For COVID, Vows More Drug Approvals :: Pink Sheet
China manufactures first COVID-19 antiviral pill, adding oral option - CGTN
Vaccines | Free Full-Text | A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
Domestically developed drug joins virus battle - Chinadaily.com.cn
People's Daily, China on Twitter: "Azvudine, China's first domestically developed oral drug for #COVID19 treatment, has set its initial price at less than 300 yuan ($44.4) per bottle, which contains 35 tablets,
SHANGHAI, CHINA - JANUARY 6, 2023 - Azvudine tablets in Shanghai, China, January 6, 2022. Azvudine tablet is an oral small-molecule COVID-19 treatment drug independently developed in China, which can be used
Merck in Deal With Sinopharm to Bring Covid Antiviral Molnupiravir to China - Bloomberg
Anti-COVID pill subject to medical supervision - SHINE News
4′-Modified Nucleosides for Antiviral Drug Discovery: Achievements and Perspectives | Accounts of Chemical Research
Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
Approved HIV reverse transcriptase inhibitors in the past decade - ScienceDirect
Analysis: How Azvudine Became China's First Approved Homegrown Covid Pill - Caixin Global
Taizhou pharmaceutical company given green light to manufacture Azvudine
